Effects of THC on Alcohol Consumption and Neural Correlates of Reward
NCT ID: NCT06446479
Last Updated: 2024-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE2
28 participants
INTERVENTIONAL
2024-07-01
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using Imaging to Assess Effects of THC on Brain Activity
NCT03655717
Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment
NCT06293040
The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment
NCT04931095
Evaluating Cannabidiol as a Novel Anticraving Medication for Alcohol Use Disorder
NCT06512389
Neuroscience of Alcohol and Marijuana Impaired Driving
NCT03431987
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo first, Dronabinol second
This arm will receive placebo on the first visit, and dronabinol on the second visit
Dronabinol Pill
Dronabinol 20 mg
Placebo
placebo
Dronabinol first, Placebo second
This arm will receive dronabinol on the first visit, and placebo on the second visit.
Dronabinol Pill
Dronabinol 20 mg
Placebo
placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dronabinol Pill
Dronabinol 20 mg
Placebo
placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Use cannabis
* Contact site for additional details
Exclusion Criteria
* Contact site for additional details
21 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
Colorado State University
OTHER
University of Colorado, Denver
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22-1314
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.